BSC
XBIO icon

BOLTON SECURITIES CORPORATION’s Xenetic Biosciences XBIO Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,010
Closed -$23.6K – 2038
2025
Q2 		$23.6K Hold
6,010
– – ﹤0.01% 1297
2025
Q1 		$15.7K Buy
+6,010
New +$23.5K ﹤0.01% 1340

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Sachetta
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Alexis Investment Partners
Alexis Investment Partners Montgomery, Texas $192M AUM 13.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Darwin Wealth Management
Darwin Wealth Management Tampa, Florida $378M AUM 15.4% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's XBIO Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION sold out of Xenetic Biosciences (XBIO) in Q3 2025, closing a stake of 6,010 shares — an estimated $23.6K sold.

BOLTON SECURITIES CORPORATION first reported a position in XBIO in Q1 2025 and held it in 2 quarters. The position peaked at $23.6K in Q2 2025. 10 funds tracked by Wall St. Rank hold XBIO as of Q3 2025.

  • BOLTON SECURITIES CORPORATION reported no remaining Xenetic Biosciences position as of Q3 2025 after selling out during the quarter.
  • BOLTON SECURITIES CORPORATION sold 6,010 Xenetic Biosciences shares in Q3 2025, an estimated $23.6K.
  • BOLTON SECURITIES CORPORATION first reported a position in Xenetic Biosciences in Q1 2025 and held it in 2 quarters.
  • BOLTON SECURITIES CORPORATION's Xenetic Biosciences position peaked at $23.6K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.